EMEA: Rare atypical fractures of the femur is a class effect of medicines containing bisphosphonates
April 15, 2011 – From a press release as of today, we learn the following (text unchanged from EMEA press release): The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that rare atypical fractures of …